Corline Biomedical (Sweden) Probability of Future Stock Price Finishing Under 14.9
| CLBIO Stock | SEK 6.70 0.56 9.12% |
Corline |
Corline Biomedical Target Price Odds to finish below 14.9
The tendency of Corline Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under kr 14.90 after 90 days |
| 6.70 | 90 days | 14.90 | close to 99 |
Based on a normal probability distribution, the odds of Corline Biomedical to stay under kr 14.90 after 90 days from now is close to 99 (This Corline Biomedical AB probability density function shows the probability of Corline Stock to fall within a particular range of prices over 90 days) . Probability of Corline Biomedical price to stay between its current price of kr 6.70 and kr 14.90 at the end of the 90-day period is about 89.63 .
Assuming the 90 days trading horizon Corline Biomedical AB has a beta of -0.86 suggesting Additionally Corline Biomedical AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Corline Biomedical Price Density |
| Price |
Predictive Modules for Corline Biomedical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Corline Biomedical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Corline Biomedical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Corline Biomedical is not an exception. The market had few large corrections towards the Corline Biomedical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Corline Biomedical AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Corline Biomedical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.35 | |
β | Beta against Dow Jones | -0.86 | |
σ | Overall volatility | 0.92 | |
Ir | Information ratio | -0.15 |
Corline Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Corline Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Corline Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Corline Biomedical generated a negative expected return over the last 90 days | |
| Corline Biomedical has high historical volatility and very poor performance | |
| Corline Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.06 M. Net Loss for the year was (6.92 M) with profit before overhead, payroll, taxes, and interest of 9.1 M. | |
| Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
| Roughly 55.0% of the company shares are held by company insiders |
Corline Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Corline Stock often depends not only on the future outlook of the current and potential Corline Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Corline Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.4 M | |
| Cash And Short Term Investments | 41.6 M |
Corline Biomedical Technical Analysis
Corline Biomedical's future price can be derived by breaking down and analyzing its technical indicators over time. Corline Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Corline Biomedical AB. In general, you should focus on analyzing Corline Stock price patterns and their correlations with different microeconomic environments and drivers.
Corline Biomedical Predictive Forecast Models
Corline Biomedical's time-series forecasting models is one of many Corline Biomedical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Corline Biomedical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Corline Biomedical
Checking the ongoing alerts about Corline Biomedical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Corline Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Corline Biomedical generated a negative expected return over the last 90 days | |
| Corline Biomedical has high historical volatility and very poor performance | |
| Corline Biomedical has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 7.06 M. Net Loss for the year was (6.92 M) with profit before overhead, payroll, taxes, and interest of 9.1 M. | |
| Corline Biomedical AB has accumulated about 41.63 M in cash with (4.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.45. | |
| Roughly 55.0% of the company shares are held by company insiders |
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.